Hiroaki Shimokawa, MD, PhD
October 7th, 2013
A Novel Risk Score for Predicting MACE in Patients with Vasospastic Angina
Hiroaki Shimokawa, MD, PhD
Hiroaki Shimokawa discusses his research group’s JACC study, in which they developed a comprehensive clinical risk score for VSA patients.
NEJM Journal Watch — Recent Cardiology Articles- Sex-Based Disparity in CABG Outcomes: Are We Moving Toward Parity?
- Can Genetic and Social Risk Scores Improve Cardiac Risk Prediction?
- Extensive Ablation vs. Pulmonary Vein Isolation in Persistent Atrial Fibrillation
- Can a Novel Stent Design Improve Long-Term Outcomes of Percutaneous Coronary Intervention?
- Are Angiographically-Derived Coronary Physiology Measurements Ready for Use in the Cath Lab?